Neuren Pharmaceuticals Ltd (NEU):企業のM&A・提携動向(医療分野)

【英語タイトル】Neuren Pharmaceuticals Ltd (NEU) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalDataが出版した調査資料(GDPH62188D)・商品コード:GDPH62188D
・発行会社(調査会社):GlobalData
・発行日:2017年2月17日
・ページ数:20
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Neuren Pharmaceuticals Ltd (Neuren Pharma) is a pharmaceutical company that develops drugs for brain injury, neurodevelopmental and neurodegenerative disorders. The company offers products such as NNZ-2566 and NNZ-2591. Neuren Pharma’s NNZ-2566 has a pharmacokinetic profile, which is suitable for intravenous infusion and oral delivery. The company’s NNZ-2591 crosses the blood-brain barrier in models of Parkinson’s disease and memory impairment. Its drugs are also used in neurodevelopmental disorders such as Angelman Syndrome and idiopathic autism, or neurodegenerative disorders such as Parkinson’s disease and multiple sclerosis. Neuren Pharma is headquartered in Camberwell, Victoria, Australia.

Neuren Pharmaceuticals Ltd (NEU) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Neuren Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Neuren Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Neuren Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Neuren Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Neuren Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Neuren Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Noble Life Sciences Enters Into Co-Development Agreement With Neuren Pharma 10
Equity Offering 10
Neuren Pharma Completes Private Placement Of Shares US$21 Million 10
Neuren Pharma Announces Rights Offering Of Shares For US$3 Million 11
Neuren Pharma Announces Private Placement Of Common Stock For US$3.13 Million 12
Neuren Pharma Completes Rights Issue Of Common Stock For US$4.05 Million 13
Neuren Pharma Completes Private Placement Of US$2.2 Million 15
Neuren Pharmaceuticals Ltd – Key Competitors 17
Key Employees 18
Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Neuren Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Neuren Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Neuren Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Neuren Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Neuren Pharmaceuticals Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Neuren Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Noble Life Sciences Enters Into Co-Development Agreement With Neuren Pharma 10
Neuren Pharma Completes Private Placement Of Shares US$21 Million 10
Neuren Pharma Announces Rights Offering Of Shares For US$3 Million 11
Neuren Pharma Announces Private Placement Of Common Stock For US$3.13 Million 12
Neuren Pharma Completes Rights Issue Of Common Stock For US$4.05 Million 13
Neuren Pharma Completes Private Placement Of US$2.2 Million 15
Neuren Pharmaceuticals Ltd, Key Competitors 17
Neuren Pharmaceuticals Ltd, Key Employees 18
Neuren Pharmaceuticals Ltd, Subsidiaries 19

List of Figures
Neuren Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Neuren Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Neuren Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Neuren Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Neuren Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Neuren Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Neuren Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Neuren Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

★調査レポート[Neuren Pharmaceuticals Ltd (NEU):企業のM&A・提携動向(医療分野)] (コード:GDPH62188D)販売に関する免責事項を必ずご確認ください。
★調査レポート[Neuren Pharmaceuticals Ltd (NEU):企業のM&A・提携動向(医療分野)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆